Business Press Release Tech Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial SHANGHAI, Dec. 11, 2023 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company… CISION PRNewswireDecember 11, 2023
Press Release Tech INNOVATION TO INSPIRE, A WONDEROUS FUTURE | Tianma 2023 Global Innovation Conference, Seven Innovative Achievements Unveiled XIAMEN, China, Dec. 11, 2023 /PRNewswire/ — On November 27th, Tianma Innovation Conference… CISION PRNewswireDecember 11, 2023
Business Press Release Tech Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East SINGAPORE and DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — Keppel Corporation Limited… CISION PRNewswireDecember 11, 2023
Business Press Release China Literature to Acquire Tencent Animation and Comics HONG KONG, Dec. 11, 2023 /PRNewswire/ — China Literature Limited ("China Literature"… CISION PRNewswireDecember 11, 2023
Press Release ACAMS Grants 10 CAMS Scholarships in Japan to Bolster Nation's Anti-Money Laundering Expertise Initiative supports Japan’s anti-money laundering (AML) and sanctions compliance push WASHINGTON, Dec.… CISION PRNewswireDecember 11, 2023
Business Press Release HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ — HanAll Biopharma’s partner NurrOn Pharmaceuticals… CISION PRNewswireDecember 11, 2023
Business Press Release First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent MELBOURNE, Australia and INDIANAPOLIS, Dec. 11, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX,… CISION PRNewswireDecember 11, 2023
Press Release Liangzhu Forum Enhances Cultural Exchanges among Silk Road Countries HANGZHOU, China, Dec. 11, 2023 /PRNewswire/ — A report from Xinhuanet North America: … CISION PRNewswireDecember 11, 2023
